David Capital Partners, LLC recently helped co-lead a $24.3M PIPE investment that provided Lifecore Biomedical (NASDAQ: LFCR) with the financial strength to deliver its strategy. This past week, Lifecore held an Investor Day outlining its multi-year ambitions for growth and margin expansion. We are excited to support Lifecore and its leadership team of CEO Paul Josephs and CFO Ryan D. Lake, CPA as the company works to create significant value for customers, shareholders, employees - and most importantly, for the millions of people who rely on Lifecore's life-changing products. https://lnkd.in/gj3tBkZr
David Capital Partners, LLC
投资管理
Chicago，Illinois 354 位关注者
David Capital is a long-term oriented alternative investment firm.
关于我们
David Capital Partners, LLC is a long-term oriented alternative investment firm headquartered in Chicago with offices in London.
- 网站
-
https://www.davidpartners.com
David Capital Partners, LLC的外部链接
- 所属行业
- 投资管理
- 规模
- 2-10 人
- 总部
- Chicago，Illinois
- 类型
- 私人持股
地点
-
主要
获取路线
737 N Michigan Ave
US，Illinois，Chicago，60611
David Capital Partners, LLC员工
动态
-
David Capital Partners, LLC and our Founder Adam Patinkin, CFA were featured this week in the “Graham and Doddsville” newsletter, published twice each year by The Heilbrunn Center for Graham and Dodd Investing at Columbia Business School. Columbia Business School is widely considered the home of value investing.?Professors Benjamin Graham and David Dodd pioneered the value investing approach through their classic text Security Analysis, written in 1934.?Value investing has since been carried forward by generations of their disciples and students – the most famous of whom is Warren Buffett, Chairman and CEO of Berkshire Hathaway, who studied under Benjamin Graham at Columbia Business School in the 1950’s. It is an honor to be included in the Spring 2024 edition of “Graham and Doddsville”. Of note, the conversation includes a discussion of David Capital’s long positions in Vistry Group plc (LSE:VTY), eDreams ODIGEO S.A. (Madrid:EDR), and Lifecore Biomedical, Inc. (NASDAQ:LFCR) and David Capital’s short position in Brown-Forman Corporation (NYSE:BF/B).?The full issue of the newsletter can be viewed at this link: https://lnkd.in/dFw8wcrR